Search

Your search keyword '"Migambi P"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Migambi P" Remove constraint Author: "Migambi P"
20 results on '"Migambi P"'

Search Results

1. Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial

2. Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study

4. Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

6. Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda

7. Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.

8. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned

9. Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda

12. Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

13. Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.

14. Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.

15. Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.

16. Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.

18. Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.

19. Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.

20. CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.

Catalog

Books, media, physical & digital resources